L.E.L. Hendriks

Kruithof, P. D., Dontje, A. E. W. K., Salmans, M. M. A., Winckers, K., van Geffen, W. H., Hendriks, L. E. L., Croes, S., ter Heine, R., & van Geel, R. (2026). Exploring therapeutic drug monitoring-guided direct oral anticoagulant use in patients with non-small cell lung cancer treated with small-molecule inhibitors. Thrombosis Update, 25, Article 100253. https://doi.org/10.1016/j.tru.2026.100253

Remon, J., Cascone, T., Saw, S. P. L., Frost, N., Li, M. S. C., Hendriks, L. E. L., Levy, A., Federico, A. D., Chaft, J. E., Abdelhamid, K., Awad, M., Mountzios, G., & Peters, S. (2026). Early-stage non-small-cell lung cancer: emerging treatments and evolving challenges. The Lancet Respiratory medicine, 14(10), 894-913. https://doi.org/10.1016/S2213-2600(26)00221-3

Hendriks, L. E. L., Lin, J. J., Tan, D. S. W., Acker, F., Ogliari, F. R., Meyer, M. L., Planchard, D., & Reck, M. (2026). Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies. The Lancet Respiratory medicine, 14(10), 914-934. https://doi.org/10.1016/S2213-2600(26)00253-5

Ogliari, F. R., Ferrara, M., Huijs, J., Traverso, A., Barbieri, S., Tiano, D., Scuri, P., Celada, D., Papotto, L., Mollica, L., Oresti, S., Ferrara, R., Steens, M., Steendam, C., Merlini, A., Luciani, A., Lang, D., Grisanti, S., Genova, C., ... Reni, M. (2026). AI-HOPE lung cancer: a multicenter real-world registry integrating artificial intelligence for metastatic non-small-cell lung cancer. ESMO Real-World Data and Digital Oncology, 13, Article 100736. https://doi.org/10.1016/j.esmorw.2026.100736

Jongbloed, M., De Ruysscher, D. K. M., & Hendriks, L. E. L. (2026). Concerns Regarding NSCLC Immunoradiotherapy Study Interpretability. JAMA Oncology. Advance online publication. https://doi.org/10.1001/jamaoncol.2026.2921

Brunetti, L., Colella, G., Di Fazio, G. R., La Cava, G., Santo, V., Pecci, F., Rotow, J. K., Bauman, J. R., Nassar, A. H., Adib, E., Naqash, A. R., Tagliamento, M., Ferrara, R., Citarella, F., Russano, M., Ricciuti, B., Faivre-Finn, C., Hendriks, L. E. L., Passaro, A., ... Cortellini, A. (2026). First-Line Integration of Local Ablative Therapy With EGFR Tyrosine Kinase Inhibitors in Advanced EGFR+ NSCLC: A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology, 21(8), Article 103735. https://doi.org/10.1016/j.jtho.2026.103735

Lyu, S., Reynders, K., Laven, I. E. W. G., Faes, C., Weynand, B., Hillen, L. M., De Leyn, P., Hendriks, L. E. L., Wauters, E., Lambrecht, M., Vaes, R. D. W., & De Ruysscher, D. (2026). Intratumor immune heterogeneity across simulated core biopsy sizes in non-small cell lung cancer: an exploratory study. Translational Lung Cancer Research, 15(7), Article 200. https://doi.org/10.21037/tlcr-2026-1-0017

Tagliamento, M., Bruzzone, M., Blondeaux, E., Dall'Olio, F., Aldea, M., Genova, C., Marinello, A., Remon, J., Hendriks, L. E. L., Del Mastro, L., Planchard, D., Barlesi, F., Lambertini, M., & Besse, B. (2026). Efficacy of alectinib for ALK-positive NSCLC according to tumor burden and body mass index: A pooled analysis of the randomized phase III trials ALEX and J-ALEX. European Journal of Cancer, 243, Article 116867. https://doi.org/10.1016/j.ejca.2026.116867

Sugden, B. M., Witlox, W. J. A., Cortiula, F., Hendriks, L. E. L., van Loon, J., Jacobs, M., Hattu, D., Joore, M. A., Ramaekers, B. L. T., & De Ruysscher, D. K. M. (2026). Assessing the impact of proton versus photon therapy on health-related quality of life in lung cancer. Clinical and Translational Radiation Oncology, 59, Article 101160. https://doi.org/10.1016/j.ctro.2026.101160

Ortega-Franco, A., Houda, I., Brandao, M., Pierret, T., Kaesmann, L., Giaj-Levra, N., Remon, J., Berghmans, T., Dingemans, A.-M. C., Faivre-Finn, C., & Hendriks, L. E. L. (2026). Upfront management of brain metastases in oncogene-addicted NSCLC - An EORTC survey. Lung Cancer, 217, Article 109444. https://doi.org/10.1016/j.lungcan.2026.109444